Severe Ulcerative Colitis: A Case Study in Integrative Gastroenterology
A patient with severe ulcerative colitis and a history of repeated hospitalizations experienced sustained resolution of reported symptoms and remained off ongoing biologic therapy during the documented follow-up period, following an individualized, integrative approach to care.
These case studies are shared for educational purposes only. Individual results vary and are influenced by many factors. The outcomes described are not a guarantee of similar results. Medical treatment, including medication management, should always be individualized by a qualified physician.
Privacy Notice: Certain details have been modified or omitted to protect patient privacy. The essential clinical information and reported outcomes have been preserved.
Ulcerative colitis is an inflammatory bowel disease managed with medical therapy tailored to disease severity and response. Its impact extends beyond intestinal symptoms, and stress, nervous system function, and life circumstances may influence a patient's experience of illness and overall well-being.
This case describes substantial, sustained improvement in reported symptoms alongside meaningful changes in emotional well-being and the patient's experience of life, illustrating a multidimensional approach to care.
The patient presented during an active flare of severe ulcerative colitis. The clinical history included:
Despite prior medical treatment, the condition had remained difficult to control, with recurrent flares.
In addition to the patient's gastrointestinal symptoms, the approach considered several interconnected aspects of health and well-being, including:
This approach recognizes that chronic illness can affect multiple dimensions of a person's life. Individualized care considers these factors alongside the patient's medical condition and clinical needs.
Mind–body work was an integral part of the individualized approach, alongside nutritional and other therapeutic interventions. This work included:
The approach addressed the patient's emotional well-being and personal experience alongside the physical aspects of care.
The patient experienced substantial improvement in reported symptoms, including:
The patient reported substantial improvement in gastrointestinal symptoms, including:
At a documented follow-up, the patient reported complete resolution of symptoms and had been off biologic therapy for three months. At the last documented follow-up after five visits, the patient continued to report sustained symptom resolution without ongoing biologic therapy.
Alongside the improvement in physical symptoms, the patient described a profound shift in emotional well-being and experience of life.
The patient reported:
The patient noted that external circumstances had not significantly changed, but the experience of those circumstances had.
The patient described the experience of living with ulcerative colitis as a catalyst for personal growth and a deeper understanding of self and life. What had initially been an extremely difficult period became a turning point in moving toward a more fulfilling and meaningful life.
This case illustrates how an individual's experience of improvement may extend beyond physical symptoms to include emotional well-being, self-awareness, and relationships with life circumstances.
An individualized, whole-person approach creates space to consider both physical health and the patient's lived experience. Although outcomes and experiences vary, this case highlights the value of addressing emotional well-being alongside gastrointestinal symptoms, without assuming that psychological or emotional changes alone account for the clinical outcome.
Wondering if a similar approach could help you?
For individuals navigating ulcerative colitis—especially those experiencing persistent symptoms despite standard therapies—a more comprehensive and individualized approach may offer a different path forward. Care is available for patients in New York, New Jersey, and Florida (including NYC and Miami, in-person and via telehealth).